drugset / Trial / NCT02407210
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
To investigate the efficacy and safety of azilsartan compared to olmesartan medoxomil in patients with grade I or II essential hypertension
Timeline
- Start
- 2015-01
- Primary completion
- 2015-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 20 mg | Oral |
| Subject | Azilsartan | Unknown | 40 mg | Oral |
| Comparator | Olmesartan medoxomil | Unknown | 20 mg | Oral |
| Comparator | Olmesartan medoxomil | Unknown | 40 mg | Oral |